SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $.0001 per share
- Shares outstanding
- 75,607,738
- Total 13F shares
- 77,131,944
- Share change
- -1,115,273
- Total reported value
- $2,905,842,857
- Put/Call ratio
- 689%
- Price per share
- $37.67
- Number of holders
- 207
- Value change
- -$85,605,108
- Number of buys
- 123
- Number of sells
- 92
Quarterly Holders Quick Answers
What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 85205L107:
Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
11,068,026
|
$544,768,240 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.6%
|
6,529,325
|
$321,373,376 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.2%
|
5,438,857
|
$267,700,541 | — | 31 Mar 2024 | |
| Stephen P. Squinto |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
6,333,277
mixed-class rows
|
$262,384,838 | — | 19 May 2022 | |
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
2.3%
from 13F
|
5,599,842
|
$232,561,438 | — | 12 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.4%
|
4,110,462
|
$202,318,000 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,832,413
|
$200,690,112 | — | 10 Aug 2021 | |
| Deep Track Capital, LP |
13F
|
Company |
4.6%
|
3,479,853
|
$171,278,365 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
4.5%
|
3,421,541
|
$168,408,248 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.9%
|
2,966,622
|
$146,017,134 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
2,961,624
|
$145,771,133 | — | 31 Mar 2024 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director |
—
mixed-class rows
|
3,105,653
mixed-class rows
|
$128,405,735 | — | 24 May 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
3.1%
|
2,317,810
|
$114,083,000 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3%
|
2,262,462
|
$111,358,380 | — | 31 Mar 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
2.5%
|
1,908,630
|
$93,942,769 | — | 31 Mar 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.3%
|
1,722,377
|
$84,775,396 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.1%
|
1,616,158
|
$79,548,280 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,504,703
|
$74,071,777 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2%
|
1,489,814
|
$73,328,645 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.9%
|
1,415,348
|
$69,663,429 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.7%
|
1,283,176
|
$63,157,923 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
1,025,832
|
$50,491,451 | — | 31 Mar 2024 | |
| Fiera Capital Corp |
13F
|
Company |
1.2%
|
917,275
|
$45,148,275 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
905,736
|
$44,580,326 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
867,224
|
$42,684,765 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.94%
|
710,267
|
$34,959,342 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.93%
|
705,539
|
$34,726,630 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.86%
|
648,847
|
$31,936,250 | — | 31 Mar 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.78%
|
592,528
|
$29,164,228 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
590,722
|
$29,075,338 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.77%
|
584,267
|
$28,757,622 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.77%
|
581,062
|
$28,599,894 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.77%
|
580,938
|
$28,593,768 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.74%
|
557,621
|
$27,446,085 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.72%
|
543,033
|
$26,728,084 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.7%
|
532,327
|
$26,201,136 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
517,973
|
$25,494,631 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.67%
|
507,331
|
$24,970,832 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.62%
|
465,856
|
$22,929,432 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
0.56%
|
426,768
|
$21,005,521 | — | 31 Mar 2024 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
421,583
|
$20,750,315 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.49%
|
374,101
|
$18,413,251 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.49%
|
372,074
|
$18,313,482 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.47%
|
357,436
|
$17,593,000 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.46%
|
350,000
|
$17,227,000 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.34%
|
253,703
|
$12,487,262 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.34%
|
253,632
|
$12,483,767 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.32%
|
242,173
|
$11,919,752 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.32%
|
238,545
|
$11,741,185 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
232,800
|
$11,458,418 | — | 31 Mar 2024 |
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q2 2024
As of 30 Jun 2024,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
207 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,131,944 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Deep Track Capital, LP, PRICE T ROWE ASSOCIATES INC /MD/, Boxer Capital, LLC, STATE STREET CORP, MAVERICK CAPITAL LTD, MARSHALL WACE, LLP, and LORD, ABBETT & CO. LLC.
This page lists
207
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
215
Q2 2024 holders
207
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.